Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

EQT Private Equity to sell Igenomix to Vitrolife for an enterprise value of EUR 1.25 billion

· Igenomix is a global leader in molecular genetic diagnostics for reproductive medicine and rare diseases - assisting approximately 90,000 patients per year through a diversified portfolio of in vitro fertilization (IVF) and rare diseases genetic testing services · The combination of Igenomix and Vitrolife will create a global leader in reproductive health by combining the knowledge, product portfolios and market presence of two leading companies within IVF medical devices and reproductive genetic testing services  · As part of the transaction, EQT Private Equity will become a

Vitrolife intends to carry out a directed share issue

Vitrolife AB (publ) (“Vitrolife”) has mandated Skandinaviska Enskilda Banken (“SEB”) to evaluate the conditions for carrying out a directed share issue corresponding to a value of approximately SEK 3.6 billion, through an accelerated book building procedure, based on the authorisation granted to the board of directors on the annual general meeting on 28 April 2021. The directed share issue is fully covered by subscription commitments from a number of current shareholders and new investors.Proceeds received from the directed share issue will be used to partly finance the acquisition of

Trading update for the second quarter

In regard to the acquisition of Igenomix and the subsequent directed share issue, Vitrolife is presenting sales and preliminary income for the second quarter.Second quarter · Sales amounted to SEK 382 (209) million, corresponding to an increase of 83 percent in SEK. Sales increased by 94 percent in local currency. · The preliminary operating income before depreciation and amortisation (EBITDA) amounted to SEK 134 (40) million, corresponding to a margin of 35 (19) percent. Fluctuations in exchange rates negatively impacted EBITDA by SEK 15 million. The operating income included non-

Vitrolife acquires Igenomix and creates a global leader in reproductive health

Vitrolife AB (publ) (“Vitrolife”) has entered into a definitive agreement to acquire 100% of the shares in Igenomix S.L.[1] (“Igenomix”) from EQT and other shareholders (together the “Sellers”). The combination will create a global leader in reproductive health by combining the knowledge, product portfolios and market presence of two leading companies within IVF medical devices and reproductive genetic testing services.Igenomix – a global leader in reproductive genetic testing services Igenomix is a global leader in women’s health and reproductive genetic testing services for IVF clinics

NPRO: Key information relating to the cash dividend to be paid by Norwegian Property ASA

Dividend amount: NOK 0.10 per share Last day including right: 12[th] July 2021 Ex-date: 13[th] July 2021 Record date: 14[th] July 2021 Payment date: 11[th] August 2021   For additional information, please contact: Bent Oustad, CEO, tel. +47 4801 6082, e-mail: bo@npro.noHaavard Rønning, CFO, tel. +47 400 200 19, e-mail: hr@npro.no This information is subject of the disclosure requirements according to §5-12 of the Norwegian Securities Trading Act (’Verdipapirhandelloven’).

NPRO: 2Q 2021 – Increased rental income and acquisition of Felix conference centre at Aker Brygge

Norwegian Property presents the results for Q2-2021 on 9[th] July at 08:30. Due to infection control it will only be possible to follow the presentation in Norwegian on the webcast: https://channel.royalcast.com/landingpage/hegnarmedia/20210709_1/ The net profit for the second quarter was NOK 175.8 million. This resulted in second-quarter earnings per share (EPS) of NOK 0.27. The book value of equity per share as at 30 June 2021 was NOK 18.53. The rental income amounted to NOK 228.6 million for the second quarter, up from NOK 172 million in the corresponding period of 2020. A

Mangold Insight has presented an analysis of Smoltek

Mangold Insight has today presented its first analysis in the monitoring of Smoltek Nanotech Holding AB (publ).Fund brokerage firm Mangold has initiated a monitoring of Smoltek and today presents an analysis where they state, among other things, that Smoltek is in an early commercialization phase of the capacitor technology CNF-MIM, which enables extremely thin high-performance capacitors in semiconductors, and that Smoltek has now also broadened its market outside the semiconductor industry by identifying other sectors where the company's patent-protected technology platform can create

#21-231 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

#21-230 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

SOTKAMO SILVER AB: Q2/2021 RELEASE AND WEB CAST

Press release: Stockholm, July 8, 2021, 16:30 CETSotkamo Silver AB will release Q2/2021 results on July 15, 2021, around 08:45 CET. The webcast to the investors will be held on July 15, 2021, at 10:00 Finnish time via a Teams-meeting. You can register for the meeting on the company's website at: www.silver.fi/fi/sijoittajat/ilmoittaudu  We will send registration instructions and a link to the event to those who have registered before the event. Please, make your registration by July 14, 2021. The presentation will be in Finnish, and the material is in English. The presentation

Invitation to presentation of Nordic Paper’s interim report Q2 2021

Nordic Paper’s interim report for the second quarter 2021 will be published on Tuesday 20 July at 07.30 CEST. Nordic Paper’s CEO Anita Sjölander and CFO Niclas Eriksson will present the report via an audiocasted telephone conference on the same day at 10:00 CEST. The presentation will be held in English and will be followed by a Q&A session. The presentation can be followed on:https://onlinexperiences.com/Launch/QReg/ShowUUID=DD23E1E0-953B-4D38-8DF2-F1653C00927A&LangLocaleID=1033 To participate via telephone and thereby be able to ask questions, please use any of the following

CORRECTION: Nurminen Logistics Plc: Estimated entry date of the new shares in the Trade Register

Nurminen Logistics Plc                            Stock Exchange Release July 8, 2021, at 5.00 p.m.   Correction to the stock exchange release issued by Nurminen Logistics Plc (the “Company”) on June 7, 2021, at 3:00 p.m. In the release, the assessment is based on the information received from the Finnish Patent And Registration Office at the moment that the new shares would be entered in the Trade Register by June 25 — 28, 2021. The new estimate is that the shares will be entered in the Trade Register as of July 13, 2021, after which the Company will immediately apply for the shares

The Board of Directors of DanCann Pharma A/S convenes an Extraordinary General Meeting and proposes that the Meeting resolves a directed share issue

The Board of Directors of DanCann Pharma A/S (publ) (“DanCann Pharma” or “the Company”) has today decided to convene an Extraordinary General Meeting of the Company on 23 July 2021 and proposes that the Board of Directors have the mandate to resolve a directed issue. Notice of the Extraordinary General Meeting is published and attached in this press release.The CEO of DanCann Pharma, Jeppe Krog Rasmussen, comments: I am pleased to announce that we in close contact with close parties and investors in DanCann Pharma today call for an Extraordinary General Meeting due to the proposal to

Electrolux to acquire French service provider La Compagnie du SAV (CSAV)

With the acquisition Electrolux, a leading global appliance company, strengthens its service network in France and underlines its commitment to drive circularity and the repairability of appliances.Electrolux today announced it has agreed to acquire La Compagnie du SAV (CSAV), the main French independent service provider (ISP) specialized in repairing domestic appliances. The acquisition is fully in line with the Electrolux Group strategy to offer outstanding experiences to consumers, ensuring they get the most out of their appliances during the complete lifecycle of the product. “With

Publication of prospectus prior to Initiator Pharma A/S preferential rights issue

Initiator Pharma A/S (“Initiator Pharma” or “the Company”) today announces that Finanstilsynet has approved the Company's prospectus for the forthcoming preferential rights issue and that the Company today publishes the prospectus on the Company’s website. The prospectus can be found through the following link https://initiatorpharma.com/investors/Preferential-Rights-Issue-2021/. The subscription period for the preferential rights issue will take place between 12 July and 26 July 2021. Teaser and subscription forms will be published in connection with the start of the subscription period.

Borr Drilling Limited – Notification of PDMR trades

Borr Drilling Limited (the “Company”) has today received trade notifications from the following persons discharging managerial responsibilities (“PDMRs”) as defined by the Market Abuse Regulation in their capacity as directors and officers: Director and Vice Chairman Tor Olav Trøim has purchased 200,000 shares on NYSE at a price of USD 0.7938 per share. Following the purchase, Mr. Trøim and his affiliated parties represent an ownership of 17,757,269 shares in the Company. Patrick Schorn, Chief Executive Officer of Borr Drilling has purchased 100,000 shares on NYSE at a price of USD 0.

Teddy Atlas Joines Wise Kracks Live to Discuss the Upcoming Poirier vs McGregor Bout

The Wise Kracks sports betting podcast today announced that special guest, boxing trainer Teddy Atlas will be featured in a live episode on the World Sports Network YouTube channel .The podcast hosted by professional sports bettor Bill Krackomberger and co-host Jon Orlando has made a habit of featuring diverse and talented guests. Atlas has a long and storied career as a trainer, including a fantastic run with Michael Moorer, culminating in Moorer being named world heavyweight champion in 1994, and taking Russian Alexander Povetkin to the WBA

Veidekke ASA: New operation and maintenance contracts valued at NOK 1.9 billion

During the spring Veidekke has entered into six new contracts for the operation and maintenance of national and county roads with the Norwegian Public Roads Administration and three county municipalities. The contracts have a duration from four to six years with options for extensions, and the overall value of the contracts is NOK 1.9 billion excluding VAT.Operation and maintenance includes routine operational tasks and minor maintenance tasks on the road network (including pedestrian and cycle paths) to ensure safe and efficient traffic and maintain the roads to ensure the desired service

Kemira reached a settlement with CDC in the damage claim litigation in Amsterdam related to the sodium chlorate business in 1994-2000

Kemira Oyj, Press release, July 8, 2021 at 4 pm (EEST)Kemira reached a settlement with CDC in the damage claim litigation in Amsterdam related to the sodium chlorate business in 1994-2000 Kemira Chemicals Oy, a fully owned subsidiary of Kemira Oyj reached a settlement with CDC Project 13 SA and CDC Holding SA (together “CDC”) in the damage claim litigation in Amsterdam, the Netherlands.  The settlement concerns claims assigned to CDC based on which CDC claimed compensation for alleged damages relating to the alleged old infringement of competition law in the sodium chlorate business

Hoist Finance provisions for tax risk and provides Q2 update

Due to recent correspondence with the Swedish Tax Agency concerning an ongoing tax audit regarding cross-jurisdictional allocation of profits, Hoist Finance has decided to provision for a potential tax risk. The audit has resulted in a negative advance notice from the Tax Agency with regards to a legacy setup established in 2014 for Polish assets. The process is in an early stage, but Hoist Finance has decided to provision for a potential unfavorable decision by the court. The negative impact on the Q2 result is estimated at around SEK -100m. “We believe that we have made a correct

Lennart Nilsson Award 2021 is awarded to Stephen Gschmeissner

Stephen Gschmeissner is the recipient of the 2021 Lennart Nilsson Award for his creative and ingenious efforts that enabled new scientific breakthroughs and opened new windows for observations of life.Scientific photographer Stephen Gschmeissner is one of the leading scanning microscopists in the world. He has a degree in zoology, and decades of experience in cancer research using scanning electron microscopy (SEM) at the Royal College of Surgeons and Cancer Research, UK. His technical competence with the microscopy equipment has produced the most beautiful pictures with amazing levels of

Eurocine Vaccines presented at BOS Virtual 2021

On 1 July 2021, CEO Hans Arwidsson gave a presentation at BOS, Biotech Outsourcing Strategies, Virtual 2021, which is an event arranged by Bio2Business Ltd., London. The event, which took place between 29 June and 1 July, brought together stakeholders in pharmaceutical outsourcing to share experiences and develop new business relationships.The presentation, where CEO Hans Arwidsson described the development of a chlamydia vaccine, had the title "Build a fruitful relationship in BioTech - A case of how to create a successful outsourcing partnership between a vaccine developer and a CDMO,

Össur hf: Q2 2021 Results - Conference call Thursday 22 July at 9:00 CEST

Announcement no. 14/2021 8 July 2021   Conference call on Thursday 22 July at 9:00 CEST / 7:00 GMT / 3:00 ET Össur will publish its financial results for Q2 2021 prior to market opening on Thursday 22 July. That same day at 9:00 CEST, Össur will host a conference call where Jon Sigurdsson, President and CEO, and Sveinn Solvason, CFO, will present and discuss the results of the quarter. The conference call will be conducted in English. A webcast can be followed on the Össur website: http://www.ossur.com/investors To participate in the conference call, please call one of the

ESS Rated Outstanding for High Sustainability Standards

European Spallation Source’s (ESS) strong focus on sustainability in the construction and operation of the research facility leads to new sustainability standards for research infrastructures worldwide. Recently, the ESS Office building in Lund, Sweden, was environmentally certified Outstanding under the international sustainability assessment method BREEAM.[ESS Office building ] ESS Office Building Photo: Roger Eriksson/ESS   At the end of June, ESS received the official BREEAM certificate acknowledging that the ESS Office has achieved an Outstanding level, the highest rating in

There are no items matching the current filter
There are no more items matching the current filter
Back to top